Mast Cells Positive for c-Kit Receptor and Tryptase Correlate with Angiogenesis in Cancerous and Adjacent Normal Pancreatic Tissue
Open Access
- 19 February 2021
- Vol. 10 (2), 444
- https://doi.org/10.3390/cells10020444
Abstract
Background: Mast cells (MCs) contain proangiogenic factors, in particular tryptase, associated with increased angiogenesis in several tumours. With special reference to pancreatic cancer, few data have been published on the role of MCs in angiogenesis in both pancreatic ductal adenocarcinoma tissue (PDAT) and adjacent normal tissue (ANT). In this study, density of mast cells positive for c-Kit receptor (MCDP-c-KitR), density of mast cells positive for tryptase (MCDPT), area of mast cells positive for tryptase (MCAPT), and angiogenesis in terms of microvascular density (MVD) and endothelial area (EA) were evaluated in a total of 45 PDAT patients with stage T2–3N0–1M0. Results: For each analysed tissue parameter, the mean ± standard deviation was evaluated in both PDAT and ANT and differences were evaluated by Student’s t-test (p ranged from 0.001 to 0.005). Each analysed tissue parameter was then correlated to each other one by Pearson t-test analysis (p ranged from 0.01 to 0.03). No other correlation among MCDP-c-KitR, MCDPT, MCAPT, MVD, EA and the main clinical–pathological characteristics was found. Conclusions: Our results suggest that tissue parameters increased from ANT to PDAT and that mast cells are strongly associated with angiogenesis in PDAT. On this basis, the inhibition of MCs through tyrosine kinase inhibitors, such as masitinib, or inhibition of tryptase by gabexate mesylate may become potential novel antiangiogenetic approaches in pancreatic cancer therapy.This publication has 100 references indexed in Scilit:
- Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen depositionBMC Cancer, 2014
- Mast Cells Positive to Tryptase and c-Kit Receptor Expressing Cells Correlates with Angiogenesis in Gastric Cancer Patients Surgically TreatedGastroenterology Research and Practice, 2013
- Mast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal AdenocarcinomaClinical Cancer Research, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerThe New England Journal of Medicine, 2011
- Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor ProgressionClinical Cancer Research, 2010
- Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse ModelPLOS ONE, 2010
- Mast cells as regulators of adaptive immunity to tumoursClinical and Experimental Immunology, 2008
- SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironmentBlood, 2008
- Active monomers of human β-tryptase have expanded substrate specificitiesInternational Immunopharmacology, 2007
- Mast cell tryptases and chymases in inflammation and host defenseImmunological Reviews, 2007